Suppr超能文献

将过氧化苯甲酰分类为安全有效并将标签修订为药品说明书格式;用于非处方人类用途的局部痤疮药品;最终规则。

Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for over-the-counter human use; final rule.

出版信息

Fed Regist. 2010 Mar 4;75(42):9767-77.

Abstract

We, the Food and Drug Administration (FDA), are issuing this final rule to include benzoyl peroxide as a generally recognized as safe and effective (GRASE) active ingredient in over-the-counter (OTC) topical acne drug products. In addition, this final rule includes new warnings and directions required for OTC acne drug products containing benzoyl peroxide. We are also revising labeling for OTC topical acne drug products containing resorcinol, resorcinol monoacetate, salicylic acid and/or sulfur to meet OTC drug labeling content and format requirements in a certain FDA regulation. This final rule is part of our ongoing review of OTC drug products and represents our conclusions on benzoyl peroxide in OTC acne drug products.

摘要

我们,美国食品药品监督管理局(FDA),发布本最终规则,将过氧化苯甲酰列为非处方(OTC)局部用痤疮药品中普遍认为安全有效的(GRASE)活性成分。此外,本最终规则包括含过氧化苯甲酰的OTC痤疮药品所需的新警告和使用说明。我们还在修订含间苯二酚、间苯二酚单乙酸酯、水杨酸和/或硫磺的OTC局部用痤疮药品的标签,以符合FDA某一法规中OTC药品标签的内容和格式要求。本最终规则是我们对OTC药品持续审查的一部分,代表了我们对OTC痤疮药品中过氧化苯甲酰的结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验